577 related articles for article (PubMed ID: 22283009)
1. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
2. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
3. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
6. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
Bhasin G; Kauser H; Athar M
Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
8. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
9. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
10. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice.
Wei H; Tye L; Bresnick E; Birt DF
Cancer Res; 1990 Feb; 50(3):499-502. PubMed ID: 2105157
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
13. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
Ordman AB; Cleaveland JS; Boutwell RK
Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
Kim TW; Smart RC
Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
16. Induction of papillomas with a high probability of conversion to malignancy.
Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
[TBL] [Abstract][Full Text] [Related]
17. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate.
Lutz WK; Beland PE; Candrian R; Fekete T; Fischer WH
Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):44-8. PubMed ID: 8628919
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion.
Meyer SA; Kim TW; Moser GJ; Monteiro-Riviere NA; Smart RC
Carcinogenesis; 1994 Jan; 15(1):47-52. PubMed ID: 8293547
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
Reiners JJ; Pavone A; Rupp T; Cantu AR
Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
